Cancer Biomarkers in Body Fluids
Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.
Сохранить в:
| Формат: | Online |
|---|---|
| Язык: | английский |
| Опубликовано: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Предметы: | |
| Online-ссылка: | ONIX_20230405_9783036566498_148 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
| _version_ | 1869530291734839296 |
|---|---|
| collection | Directory of Open Access Books |
| description | Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies. |
| format | Online |
| id | doab-20.500.12854ir-98869 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-988692024-03-31T13:10:46Z Cancer Biomarkers in Body Fluids Bianchi, Fabrizio primary breast cancer circulating nucleosomes circulating tumor cells plasminogen activator inhibitor-1 cytokines prostate cancer breast cancer treatment decisions exosomes molecular composition cancer pathogenesis diagnostics therapeutics leptomeningeal metastasis cerebrospinal fluid extracellular vesicle biomarker RNA sequencing small non-coding RNA microRNA exo-oncomiRNAS TWEAK semen rheumatoid factor autoimmunity autoantibodies cancer predictive biomarker prognostic biomarker cancer progression cancer development immunotherapy cancer susceptibility tumor recurrence tumor load fecal immunochemical test (FIT) colonoscopy flexible sigmoidoscopy liquid biopsy mRNA ctDNA proteins extracellular vesicles biomarkers exosome lung cancer miRNA plasma serum volatile organic compounds (VOCs) gas chromatography (GC) mass spectrometry (MS) headspace solid phase microextraction (HS-SPME) breast cancer biomarkers principal component analysis (PCA) linear discriminant analysis (LDA) principal component regression (PCR) cfDNA hereditary and familial pancreatic cancer somatic mutation profiling potentially druggable genes uveal melanoma circulating tumor DNA next generation sequencing PKC inhibitor treatment response melanoma ovarian cancer lipidomics lipid prognosis ceramide phospholipid plasmalogen patient stratification outcome personalized medicine neuroblastoma immune monitoring anti-GD2 IL-2 GM-CSF ASCT dinutuximab anti-PD-1 urothelial cancer blood biomarkers NETs disease modelling machine learning metabolic signaling molecular pathways plasma metabolites diagnostic biomarkers urine urine liquid biopsy DNA sncRNA bladder cancer metabolic pathways metabolism metabolomics epigenetics miRNAs epigenetic biomarkers DNA methylation micro-RNAs human papillomavirus oropharyngeal squamous cell carcinoma treatment de-escalation E7 oncoprotein HPV DNA HPV antibodies ELISA cancer biomarkers diagnosis early detection n/a early diagnosis thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies. 2023-04-05T12:56:25Z 2023-04-05T12:56:25Z 2023 book ONIX_20230405_9783036566498_148 9783036566498 9783036566481 https://directory.doabooks.org/handle/20.500.12854/98869 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/6922 https://mdpi.com/books/pdfview/book/6922 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-6648-1 10.3390/books978-3-0365-6648-1 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036566498 9783036566481 490 Basel open access |
| spellingShingle | primary breast cancer circulating nucleosomes circulating tumor cells plasminogen activator inhibitor-1 cytokines prostate cancer breast cancer treatment decisions exosomes molecular composition cancer pathogenesis diagnostics therapeutics leptomeningeal metastasis cerebrospinal fluid extracellular vesicle biomarker RNA sequencing small non-coding RNA microRNA exo-oncomiRNAS TWEAK semen rheumatoid factor autoimmunity autoantibodies cancer predictive biomarker prognostic biomarker cancer progression cancer development immunotherapy cancer susceptibility tumor recurrence tumor load fecal immunochemical test (FIT) colonoscopy flexible sigmoidoscopy liquid biopsy mRNA ctDNA proteins extracellular vesicles biomarkers exosome lung cancer miRNA plasma serum volatile organic compounds (VOCs) gas chromatography (GC) mass spectrometry (MS) headspace solid phase microextraction (HS-SPME) breast cancer biomarkers principal component analysis (PCA) linear discriminant analysis (LDA) principal component regression (PCR) cfDNA hereditary and familial pancreatic cancer somatic mutation profiling potentially druggable genes uveal melanoma circulating tumor DNA next generation sequencing PKC inhibitor treatment response melanoma ovarian cancer lipidomics lipid prognosis ceramide phospholipid plasmalogen patient stratification outcome personalized medicine neuroblastoma immune monitoring anti-GD2 IL-2 GM-CSF ASCT dinutuximab anti-PD-1 urothelial cancer blood biomarkers NETs disease modelling machine learning metabolic signaling molecular pathways plasma metabolites diagnostic biomarkers urine urine liquid biopsy DNA sncRNA bladder cancer metabolic pathways metabolism metabolomics epigenetics miRNAs epigenetic biomarkers DNA methylation micro-RNAs human papillomavirus oropharyngeal squamous cell carcinoma treatment de-escalation E7 oncoprotein HPV DNA HPV antibodies ELISA cancer biomarkers diagnosis early detection n/a early diagnosis thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Cancer Biomarkers in Body Fluids |
| title | Cancer Biomarkers in Body Fluids |
| title_full | Cancer Biomarkers in Body Fluids |
| title_fullStr | Cancer Biomarkers in Body Fluids |
| title_full_unstemmed | Cancer Biomarkers in Body Fluids |
| title_short | Cancer Biomarkers in Body Fluids |
| title_sort | cancer biomarkers in body fluids |
| topic | primary breast cancer circulating nucleosomes circulating tumor cells plasminogen activator inhibitor-1 cytokines prostate cancer breast cancer treatment decisions exosomes molecular composition cancer pathogenesis diagnostics therapeutics leptomeningeal metastasis cerebrospinal fluid extracellular vesicle biomarker RNA sequencing small non-coding RNA microRNA exo-oncomiRNAS TWEAK semen rheumatoid factor autoimmunity autoantibodies cancer predictive biomarker prognostic biomarker cancer progression cancer development immunotherapy cancer susceptibility tumor recurrence tumor load fecal immunochemical test (FIT) colonoscopy flexible sigmoidoscopy liquid biopsy mRNA ctDNA proteins extracellular vesicles biomarkers exosome lung cancer miRNA plasma serum volatile organic compounds (VOCs) gas chromatography (GC) mass spectrometry (MS) headspace solid phase microextraction (HS-SPME) breast cancer biomarkers principal component analysis (PCA) linear discriminant analysis (LDA) principal component regression (PCR) cfDNA hereditary and familial pancreatic cancer somatic mutation profiling potentially druggable genes uveal melanoma circulating tumor DNA next generation sequencing PKC inhibitor treatment response melanoma ovarian cancer lipidomics lipid prognosis ceramide phospholipid plasmalogen patient stratification outcome personalized medicine neuroblastoma immune monitoring anti-GD2 IL-2 GM-CSF ASCT dinutuximab anti-PD-1 urothelial cancer blood biomarkers NETs disease modelling machine learning metabolic signaling molecular pathways plasma metabolites diagnostic biomarkers urine urine liquid biopsy DNA sncRNA bladder cancer metabolic pathways metabolism metabolomics epigenetics miRNAs epigenetic biomarkers DNA methylation micro-RNAs human papillomavirus oropharyngeal squamous cell carcinoma treatment de-escalation E7 oncoprotein HPV DNA HPV antibodies ELISA cancer biomarkers diagnosis early detection n/a early diagnosis thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | primary breast cancer circulating nucleosomes circulating tumor cells plasminogen activator inhibitor-1 cytokines prostate cancer breast cancer treatment decisions exosomes molecular composition cancer pathogenesis diagnostics therapeutics leptomeningeal metastasis cerebrospinal fluid extracellular vesicle biomarker RNA sequencing small non-coding RNA microRNA exo-oncomiRNAS TWEAK semen rheumatoid factor autoimmunity autoantibodies cancer predictive biomarker prognostic biomarker cancer progression cancer development immunotherapy cancer susceptibility tumor recurrence tumor load fecal immunochemical test (FIT) colonoscopy flexible sigmoidoscopy liquid biopsy mRNA ctDNA proteins extracellular vesicles biomarkers exosome lung cancer miRNA plasma serum volatile organic compounds (VOCs) gas chromatography (GC) mass spectrometry (MS) headspace solid phase microextraction (HS-SPME) breast cancer biomarkers principal component analysis (PCA) linear discriminant analysis (LDA) principal component regression (PCR) cfDNA hereditary and familial pancreatic cancer somatic mutation profiling potentially druggable genes uveal melanoma circulating tumor DNA next generation sequencing PKC inhibitor treatment response melanoma ovarian cancer lipidomics lipid prognosis ceramide phospholipid plasmalogen patient stratification outcome personalized medicine neuroblastoma immune monitoring anti-GD2 IL-2 GM-CSF ASCT dinutuximab anti-PD-1 urothelial cancer blood biomarkers NETs disease modelling machine learning metabolic signaling molecular pathways plasma metabolites diagnostic biomarkers urine urine liquid biopsy DNA sncRNA bladder cancer metabolic pathways metabolism metabolomics epigenetics miRNAs epigenetic biomarkers DNA methylation micro-RNAs human papillomavirus oropharyngeal squamous cell carcinoma treatment de-escalation E7 oncoprotein HPV DNA HPV antibodies ELISA cancer biomarkers diagnosis early detection n/a early diagnosis thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230405_9783036566498_148 |